Pfizer Inc. (PFE)
26.28
+0.68
(+2.66%)
USD |
NYSE |
Jun 11, 14:10
Pfizer Total Liabilities (Quarterly) : 117.21B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 117.21B |
| December 31, 2025 | 121.38B |
| September 30, 2025 | 115.64B |
| June 30, 2025 | 117.08B |
| March 31, 2025 | 117.39B |
| December 31, 2024 | 124.90B |
| September 30, 2024 | 126.92B |
| June 30, 2024 | 128.22B |
| March 31, 2024 | 128.54B |
| December 31, 2023 | 137.21B |
| September 30, 2023 | 117.82B |
| June 30, 2023 | 120.87B |
| March 31, 2023 | 94.38B |
| December 31, 2022 | 101.29B |
| September 30, 2022 | 102.46B |
| June 30, 2022 | 107.82B |
| March 31, 2022 | 101.16B |
| December 31, 2021 | 104.01B |
| September 30, 2021 | 103.22B |
| June 30, 2021 | 99.60B |
| March 31, 2021 | 89.95B |
| December 31, 2020 | 90.76B |
| September 30, 2020 | 113.49B |
| June 30, 2020 | 113.37B |
| March 31, 2020 | 101.00B |
| Date | Value |
|---|---|
| December 31, 2019 | 104.04B |
| September 30, 2019 | 105.05B |
| June 30, 2019 | 96.27B |
| March 31, 2019 | 96.26B |
| December 31, 2018 | 95.66B |
| September 30, 2018 | 96.17B |
| June 30, 2018 | 94.86B |
| March 31, 2018 | 94.07B |
| December 31, 2017 | 100.14B |
| September 30, 2017 | 111.04B |
| June 30, 2017 | 109.86B |
| March 31, 2017 | 110.04B |
| December 31, 2016 | 111.78B |
| September 30, 2016 | 114.83B |
| June 30, 2016 | 107.59B |
| March 31, 2016 | 99.58B |
| December 31, 2015 | 102.46B |
| September 30, 2015 | 103.74B |
| June 30, 2015 | 93.70B |
| March 31, 2015 | 93.05B |
| December 31, 2014 | 97.65B |
| September 30, 2014 | 93.06B |
| June 30, 2014 | 95.66B |
| March 31, 2014 | 93.74B |
| December 31, 2013 | 95.48B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 119.71B |
| Eli Lilly & Co. | 85.38B |
| Merck & Co., Inc. | 82.75B |
| Viatris, Inc. | 22.18B |
| Bristol Myers Squibb Co. | 66.37B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.62B |
| Shareholders Equity (Quarterly) | 90.10B |
| Debt to Equity Ratio | 0.7154 |
| Current Ratio | 1.247 |
| Net Debt Paydown Yield | 0.32% |